Copyright Reports & Markets. All rights reserved.

Global Parkinsons Disease Drugs Sales Market Report 2019 by Manufacturer, Region, Type and Application

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Parkinsons Disease Drugs Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Madopar
      • 2.1.2 Sinemet-CR
      • 2.1.3 Trastal
      • 2.1.4 COMT Inhibitor
      • 2.1.5 Other
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Madopar
      • 2.2.2 Sinemet-CR
      • 2.2.3 Trastal
      • 2.2.4 COMT Inhibitor
      • 2.2.5 Other

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Under 40 Years Old
      • 3.1.2 40-65 Years Old
      • 3.1.3 Above 65 Years Old

    4 Manufacturers Profiles/Analysis

    • 4.1 GSK
      • 4.1.1 GSK Profiles
      • 4.1.2 GSK Product Information
      • 4.1.3 GSK Parkinsons Disease Drugs Business Performance
      • 4.1.4 GSK Parkinsons Disease Drugs Business Development and Market Status
    • 4.2 Novartis
      • 4.2.1 Novartis Profiles
      • 4.2.2 Novartis Product Information
      • 4.2.3 Novartis Parkinsons Disease Drugs Business Performance
      • 4.2.4 Novartis Parkinsons Disease Drugs Business Development and Market Status
    • 4.3 Boehringer Ingelheim
      • 4.3.1 Boehringer Ingelheim Profiles
      • 4.3.2 Boehringer Ingelheim Product Information
      • 4.3.3 Boehringer Ingelheim Parkinsons Disease Drugs Business Performance
      • 4.3.4 Boehringer Ingelheim Parkinsons Disease Drugs Business Development and Market Status
    • 4.4 Teva Pharmaceutical
      • 4.4.1 Teva Pharmaceutical Profiles
      • 4.4.2 Teva Pharmaceutical Product Information
      • 4.4.3 Teva Pharmaceutical Parkinsons Disease Drugs Business Performance
      • 4.4.4 Teva Pharmaceutical Parkinsons Disease Drugs Business Development and Market Status
    • 4.5 Abbvie
      • 4.5.1 Abbvie Profiles
      • 4.5.2 Abbvie Product Information
      • 4.5.3 Abbvie Parkinsons Disease Drugs Business Performance
      • 4.5.4 Abbvie Parkinsons Disease Drugs Business Development and Market Status
    • 4.6 Merck
      • 4.6.1 Merck Profiles
      • 4.6.2 Merck Product Information
      • 4.6.3 Merck Parkinsons Disease Drugs Business Performance
      • 4.6.4 Merck Parkinsons Disease Drugs Business Development and Market Status
    • 4.7 Akorn
      • 4.7.1 Akorn Profiles
      • 4.7.2 Akorn Product Information
      • 4.7.3 Akorn Parkinsons Disease Drugs Business Performance
      • 4.7.4 Akorn Parkinsons Disease Drugs Business Development and Market Status
    • 4.8 Kyowa Hakko Kirin Pharma
      • 4.8.1 Kyowa Hakko Kirin Pharma Profiles
      • 4.8.2 Kyowa Hakko Kirin Pharma Product Information
      • 4.8.3 Kyowa Hakko Kirin Pharma Parkinsons Disease Drugs Business Performance
      • 4.8.4 Kyowa Hakko Kirin Pharma Parkinsons Disease Drugs Business Development and Market Status
    • 4.9 Astellas Pharma
      • 4.9.1 Astellas Pharma Profiles
      • 4.9.2 Astellas Pharma Product Information
      • 4.9.3 Astellas Pharma Parkinsons Disease Drugs Business Performance
      • 4.9.4 Astellas Pharma Parkinsons Disease Drugs Business Development and Market Status
    • 4.10 Desitin Arzneimittel
      • 4.10.1 Desitin Arzneimittel Profiles
      • 4.10.2 Desitin Arzneimittel Product Information
      • 4.10.3 Desitin Arzneimittel Parkinsons Disease Drugs Business Performance
      • 4.10.4 Desitin Arzneimittel Parkinsons Disease Drugs Business Development and Market Status
    • 4.11 Endo Pharmaceuticals
    • 4.12 F.Hoffmann-La Roche
    • 4.13 H.Lundbeck
    • 4.14 Valeant
    • 4.15 Apokyn
    • 4.16 Orion
    • 4.17 Stada Arzneimittel
    • 4.18 US WorldMeds
    • 4.19 Valeant Pharmaceuticals

    5 Market Performance for Manufacturers

    • 5.1 Global Parkinsons Disease Drugs Sales (K Units) and Market Share by Manufacturers 2014-2019
    • 5.2 Global Parkinsons Disease Drugs Revenue (M USD) and Market Share by Manufacturers 2014-2019
    • 5.3 Global Parkinsons Disease Drugs Price (USD/Unit) of Manufacturers 2014-2019
    • 5.4 Global Parkinsons Disease Drugs Gross Margin of Manufacturers 2014-2019
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Parkinsons Disease Drugs Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.1.2 China Parkinsons Disease Drugs Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.1.3 China Parkinsons Disease Drugs Price (USD/Unit) of Manufacturers 2014-2019
      • 6.1.4 China Parkinsons Disease Drugs Gross Margin of Manufacturers 2014-2019
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Parkinsons Disease Drugs Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.2.2 USA Parkinsons Disease Drugs Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.2.3 USA Parkinsons Disease Drugs Price (USD/Unit) of Manufacturers 2014-2019
      • 6.2.4 USA Parkinsons Disease Drugs Gross Margin of Manufacturers 2014-2019
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Parkinsons Disease Drugs Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.3.2 Europe Parkinsons Disease Drugs Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.3.3 Europe Parkinsons Disease Drugs Price (USD/Unit) of Manufacturers 2014-2019
      • 6.3.4 Europe Parkinsons Disease Drugs Gross Margin of Manufacturers 2014-2019
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Parkinsons Disease Drugs Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.4.2 Japan Parkinsons Disease Drugs Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.4.3 Japan Parkinsons Disease Drugs Price (USD/Unit) of Manufacturers 2014-2019
      • 6.4.4 Japan Parkinsons Disease Drugs Gross Margin of Manufacturers 2014-2019
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Parkinsons Disease Drugs Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.5.2 Korea Parkinsons Disease Drugs Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.5.3 Korea Parkinsons Disease Drugs Price (USD/Unit) of Manufacturers 2014-2019
      • 6.5.4 Korea Parkinsons Disease Drugs Gross Margin of Manufacturers 2014-2019
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Parkinsons Disease Drugs Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.6.2 India Parkinsons Disease Drugs Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.6.3 India Parkinsons Disease Drugs Price (USD/Unit) of Manufacturers 2014-2019
      • 6.6.4 India Parkinsons Disease Drugs Gross Margin of Manufacturers 2014-2019
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Parkinsons Disease Drugs Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.7.2 Southeast Asia Parkinsons Disease Drugs Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.7.3 Southeast Asia Parkinsons Disease Drugs Price (USD/Unit) of Manufacturers 2014-2019
      • 6.7.4 Southeast Asia Parkinsons Disease Drugs Gross Margin of Manufacturers 2014-2019
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Parkinsons Disease Drugs Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.8.2 South America Parkinsons Disease Drugs Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.8.3 South America Parkinsons Disease Drugs Price (USD/Unit) of Manufacturers 2014-2019
      • 6.8.4 South America Parkinsons Disease Drugs Gross Margin of Manufacturers 2014-2019
      • 6.8.5 Market Concentration

    7 Global Parkinsons Disease Drugs Market Performance (Sales Point)

    • 7.1 Global Parkinsons Disease Drugs Sales (K Units) and Market Share by Regions 2014-2019
    • 7.2 Global Parkinsons Disease Drugs Revenue (M USD) and Market Share by Regions 2014-2019
    • 7.3 Global Parkinsons Disease Drugs Price (USD/Unit) by Regions 2014-2019
    • 7.4 Global Parkinsons Disease Drugs Gross Margin by Regions 2014-2019

    8 Development Trend for Regions (Sales Point)

    • 8.1 Global Parkinsons Disease Drugs Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.2 China Parkinsons Disease Drugs Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.3 USA Parkinsons Disease Drugs Sales and Growth, Sales Value and Growth Rate2014-2019
    • 8.4 Europe Parkinsons Disease Drugs Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.5 Japan Parkinsons Disease Drugs Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.6 Korea Parkinsons Disease Drugs Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.7 India Parkinsons Disease Drugs Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.8 Southeast Asia Parkinsons Disease Drugs Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.8 Southeast Asia Parkinsons Disease Drugs Sales and Growth, Sales Value and Growth Rate 2014-2019

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Under 40 Years Old Industry
    • 11.2 40-65 Years Old Industry
    • 11.3 Above 65 Years Old Industry

    12 Market Forecast 2020-2025

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2020-2025
      • 12.1.1 Global Parkinsons Disease Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2020-2025
      • 12.1.2 Global Parkinsons Disease Drugs Sales (K Units) and Growth Rate 2020-2025
      • 12.1.3 China Parkinsons Disease Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.4 USA Parkinsons Disease Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.5 Europe Parkinsons Disease Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.6 Japan Parkinsons Disease Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.7 Korea Parkinsons Disease Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.8 India Parkinsons Disease Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.9 Southeast Asia Parkinsons Disease Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.10 South America Parkinsons Disease Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2020-2025
      • 12.2.1 Overall Market Performance
      • 12.2.2 Madopar
      • 12.2.3 Sinemet-CR
      • 12.2.4 Trastal
      • 12.2.5 COMT Inhibitor
      • 12.2.6 Other
    • 12.3 Sales (K Units) Forecast by Application 2020-2025
      • 12.3.1 Overall Market Performance
      • 12.3.2 Under 40 Years Old
      • 12.3.3 40-65 Years Old
      • 12.3.4 Above 65 Years Old
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Parkinsons Disease Drugs Price (USD/Unit) Trend 2020-2025
      • 12.4.2 Global Parkinsons Disease Drugs Gross Profit Trend 2020-2025

    13 Conclusion

    Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Parkinsons Disease Drugs for these regions, from 2012 to 2023 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    Global Parkinsons Disease Drugs market competition by top manufacturers/players, with Parkinsons Disease Drugs sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    GSK
    Novartis
    Boehringer Ingelheim
    Teva Pharmaceutical
    Abbvie
    Merck
    Akorn
    Kyowa Hakko Kirin Pharma
    Astellas Pharma
    Desitin Arzneimittel
    Endo Pharmaceuticals
    F.Hoffmann-La Roche
    H.Lundbeck
    Valeant
    Apokyn
    Orion
    Stada Arzneimittel
    US WorldMeds
    Valeant Pharmaceuticals
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Madopar
    Sinemet-CR
    Trastal
    COMT Inhibitor
    Other
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Parkinsons Disease Drugs for each application, including
    Under 40 Years Old
    40-65 Years Old
    Above 65 Years Old

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now